Free Trial

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$2.57 +0.04 (+1.58%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.56 -0.01 (-0.54%)
As of 04/17/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DRTS vs. AXGN, EMBC, IRMD, BVS, BFLY, RXST, AVNS, SIBN, CBLL, and KIDS

Should you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), Bioventus (BVS), Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), SI-BONE (SIBN), CeriBell (CBLL), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Alpha Tau Medical vs.

Alpha Tau Medical (NASDAQ:DRTS) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk, community ranking and dividends.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 7.0% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

AxoGen has higher revenue and earnings than Alpha Tau Medical. AxoGen is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$29.16M-$0.45-5.71
AxoGen$187.34M3.69-$21.72M-$0.22-70.77

Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 211.28%. AxoGen has a consensus target price of $22.60, indicating a potential upside of 45.15%. Given Alpha Tau Medical's higher probable upside, research analysts plainly believe Alpha Tau Medical is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
AxoGen
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Alpha Tau Medical has a net margin of 0.00% compared to AxoGen's net margin of -7.91%. AxoGen's return on equity of -14.91% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -38.62% -29.89%
AxoGen -7.91%-14.91%-7.49%

Alpha Tau Medical has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.

AxoGen received 437 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 71.43% of users gave Alpha Tau Medical an outperform vote.

CompanyUnderperformOutperform
Alpha Tau MedicalOutperform Votes
20
71.43%
Underperform Votes
8
28.57%
AxoGenOutperform Votes
457
72.89%
Underperform Votes
170
27.11%

In the previous week, AxoGen had 7 more articles in the media than Alpha Tau Medical. MarketBeat recorded 8 mentions for AxoGen and 1 mentions for Alpha Tau Medical. AxoGen's average media sentiment score of 1.13 beat Alpha Tau Medical's score of 1.00 indicating that AxoGen is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Positive
AxoGen Positive

Summary

AxoGen beats Alpha Tau Medical on 12 of the 16 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$180.88M$4.04B$5.30B$7.35B
Dividend YieldN/A39.51%5.12%4.30%
P/E Ratio-5.9827.6821.8017.80
Price / SalesN/A47.06379.9697.74
Price / CashN/A51.0838.2634.64
Price / Book2.125.816.443.98
Net Income-$29.16M$67.09M$3.21B$247.73M
7 Day Performance0.78%1.97%2.87%1.81%
1 Month Performance-1.91%-4.84%-8.63%-6.98%
1 Year Performance-3.38%14.47%11.46%1.37%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
2.6535 of 5 stars
$2.57
+1.6%
$8.00
+211.3%
-4.5%$180.88MN/A-5.9880Short Interest ↓
News Coverage
Gap Down
AXGN
AxoGen
2.9717 of 5 stars
$16.06
+1.1%
$22.60
+40.7%
+124.4%$712.17M$187.34M-50.19450Short Interest ↑
Positive News
EMBC
Embecta
4.5127 of 5 stars
$11.90
-3.3%
$20.33
+70.9%
+10.7%$691.80M$1.11B11.901,900Gap Down
IRMD
Iradimed
4.8749 of 5 stars
$53.03
+1.4%
$72.00
+35.8%
+27.9%$674.28M$73.24M35.35110Short Interest ↓
Positive News
BVS
Bioventus
3.2028 of 5 stars
$7.92
+5.9%
$15.00
+89.4%
+66.4%$612.94M$573.28M-12.981,200News Coverage
Positive News
Gap Down
BFLY
Butterfly Network
2.4745 of 5 stars
$2.53
+2.8%
$3.00
+18.6%
+185.0%$597.59M$82.06M-5.50460News Coverage
Gap Down
RXST
RxSight
3.0282 of 5 stars
$14.42
+2.4%
$39.78
+175.9%
-72.7%$583.88M$139.93M-17.37220Analyst Forecast
News Coverage
Gap Up
AVNS
Avanos Medical
3.2228 of 5 stars
$12.42
-0.4%
N/A-33.7%$571.36M$687.80M36.534,040
SIBN
SI-BONE
4.1647 of 5 stars
$13.36
-0.1%
$24.40
+82.6%
-9.1%$567.17M$167.18M-14.52350Positive News
Gap Down
CBLL
CeriBell
N/A$14.88
-0.8%
$32.50
+118.4%
N/A$533.72M$65.44M0.00N/AGap Up
KIDS
OrthoPediatrics
4.3193 of 5 stars
$20.98
-0.9%
$37.00
+76.4%
-29.8%$509.54M$204.73M-17.06200

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners